Simcere Announces 105 Drugs Included in China's National Drug Reimburs... (the treatment of diseases with high inci...)

(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...

(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...

(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...

(Date:5/21/2013)... Md. , May 21, 2013 MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM. The presentation ...

Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4 Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)[0] Study led by GW professor provides better understanding of water's freezing behavior at nanoscale [0] Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... Funds will extend the National ... Honolulu, HI ... $2.8 million in research funding from the National Cancer Institute (NCI) to continue the National ... years. , , , , ,Since 2002, PHRI has participated in the NLST, a research ...

... Stemedica ... today that it has been granted a license by the State of California,s Food ... Manufacturing License recognizes Stemedica as being compliant with California law and the applicable provisions ... ...

... , ... DeSilva + Phillips, Media Investment Bankers, has ... M&A practice. Formerly CEO of IncumediX and COO/CSO at MediServe Information ... on over 140 transactions, including acquisitions, technology license and partnership deals, ...

Cached Biology Technology:Pacific Health Research Institute Awarded $2.8 Million in Research Funding 2 Pacific Health Research Institute Awarded $2.8 Million in Research Funding 3 Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 2 Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 3 DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice 2 DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice 3

Pacific Health Research Institute Awarded $2.8 Million in Research Funding Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice

(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...

(Date:5/21/2013)... method for delivering molecules into single, targeted cells ... technique could find applications in drug delivery, cell ... a technique used to deliver molecules into ... that are caused by exposing them to electric ... cell transfection. (Cell transfection is the introduction of ...

(Date:5/21/2013)... University of Illinois at Chicago College of Medicine will study ... -- its main energy source -- and how changes in ... new $2 million, 4-year grant from the National Heart, Lung ... it uses fuel for energy. These changes may play a ... different in men and women, says E. Douglas Lewandowski, director ...

Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2 Do men's and women's hearts burn fuel differently? 2

[0] Book explores place-based conservation as framework [0] Single-cell transfection tool enables added control for biological studies [0] Do men's and women's hearts burn fuel differently?

... Aware, Inc. (Nasdaq: AWRE ), a leading supplier ... call to discuss the company,s operating results for the first ... Eastern Time. CEO Michael Tzannes and CFO Rick Moberg will ... Thomson and can be accessed on the Investor Relations page ...

... Park, Md. -- DNA sequencing is the next frontier ... and affordable, it is increasingly available to small laboratories. ... faster rate than ever before. However, the computing ... still has some catching up to do. Large ...

... We have the will but do we have the technology? ... being held May 13 to 15, 2009 at McMaster University ... climate change and global warming. Among the guest speakers ... of Canada and former Premier of Manitoba. He will ...

Cached Biology News:Aware, Inc. Announces Q1 '09 Earnings Conference Call 2 A genomic CluE for cloud computing 2 A genomic CluE for cloud computing 3

Aware, Inc. Announces Q1 '09 Earnings Conference Call A genomic CluE for cloud computing Conference tackles technology needed to address climate change

No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....

12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....

...

Biology Products:

Rabbit Anti-Human Q96DQ3 Polyclonal Antibody, Unconjugated from Atlas Antibodies 12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical Silencer Pre-designed siRNA, standard purity, annealed from Ambion Silencer Validated siRNA - with sequence information 20 nmol from Ambion